Anteris Technologies Global Corp.

AVR

Company Profile

  • Business description

    Anteris Technologies Global Corp. is a structural heart company committed to discovering, developing and commercializing medical devices designed to improve the quality of life for patients with aortic stenosis. Its product, the DurAVR THV system, represents a product opportunity in a new THV class of single-piece heart valves, for the treatment of aortic stenosis. Its DurAVR THV system consists of a single-piece, biomimetic valve made with its proprietary ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold.

  • Contact

    9 Sherwood Road
    Toowong Tower, Level 3, Suite 302
    Toowong,QLD4066
    AUS

    T: +61 731523200

    https://www.anteristech.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    31 December 2025

    Employees

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,766.0075.100.86%
CAC 407,763.8426.640.34%
DAX 4024,091.62160.950.67%
Dow JONES (US)42,519.64214.160.51%
FTSE 1008,787.0212.760.15%
HKSE23,680.73168.240.72%
NASDAQ19,398.96156.340.81%
Nikkei 22537,775.04328.230.88%
NZX 50 Index12,479.28152.051.23%
S&P 5005,970.3734.430.58%
S&P/ASX 2008,539.3072.600.86%
SSE Composite Index3,376.5814.610.43%

Market Movers